37005-79-1

Basic information

• Product Name: Benzene, [(3-cyclopenten-1-yloxy)methyl]-
• CAS NO: 37005-79-1
• Molecular Formula: C12H14O
• Molecular Weight: 174.243
• Mol File: 37005-79-1.mol
• Article Data: 20

Chemical Properties

• CAS DataBase Reference: Benzene, [(3-cyclopenten-1-yloxy)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, [(3-cyclopenten-1-yloxy)methyl]-(37005-79-1)
• EPA Substance Registry System: Benzene, [(3-cyclopenten-1-yloxy)methyl]-(37005-79-1)

Safety Data

• Hazardous Substances Data: 37005-79-1(Hazardous Substances Data)

Usage

General Description

Benzene, [(3-cyclopenten-1-yloxy)methyl]- is a chemical compound with the molecular formula C13H14O. It is a derivative of benzene with a cyclopenten-1-yloxy methyl group attached to one of its carbon atoms. Benzene, [(3-cyclopenten-1-yloxy)methyl]- is often used in organic synthesis and as a building block for the preparation of various pharmaceuticals and agrochemicals. It is also utilized in the production of perfumes, flavorings, and other fine chemicals. The structure and properties of this compound make it useful in a wide range of industrial applications.

Upstream product

• 100-44-7 benzyl chloride 
• 2883-45-6 1, 6-heptadien-4-ol 
• 7129-41-1 6-oxabicyclo[3.1.0]hex-2-ene 
• 247936-95-4 Tricyclo<5.2.1.0^2.6>deca-3,8-dien 
• 77-73-6 bi(cyclopentadiene) 
• 542-92-7 cyclopenta-1,3-diene 
• 144675-80-9 1-((hepta-1,6-dien-4-yloxy)methyl)benzene 
• 14320-38-8 cyclopent-3-enol 
• 100-39-0 benzyl bromide 

Downstream Products

• 1312692-53-7 (1R,2R,4R)-2-azido-4-(benzyloxy)cyclopentyl methanesulfonate 

Relevant articles and documents

5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY

The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK

This invention relates to inhibitors of NTRK that are active against wild-type NTRK and its resistant mutants.

Lewis acid assisted ruthenium-catalyzed metathesis reactions

The combination of a ruthenium-arene complex, a noncoordinating salt, and a Lewis acid facilitates access to a highly active and selective in situ metathesis catalyst. The catalyst is formed from an inexpensive ruthenium precursor and olefins are used as the substrates. RCM=Ring-closing metathesis, acac=acetylacetonate. Copyright